Profile data is unavailable for this security.
About the company
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
- Revenue in DKK (TTM)17.55bn
- Net income in DKK3.68bn
- Incorporated2000
- Employees6.44k
- LocationNovozymes A/SKrogshoejvej 36BAGSVAERD 2880DenmarkDNK
- Phone+45 44460000
- Fax+45 44469999
- Websitehttps://www.novozymes.com/
More ▼
Mergers & acquisitions
| Acquired company | NZYM B:CPH since announced | Transaction value |
|---|---|---|
| Chr Hansen Holding A/S | -19.56% | 1.81bn |
| Chr Hansen Holding A/S | -19.56% | 9.62bn |
Data delayed at least 15 minutes, as of Jan 27 2023 15:59 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azelis Group NV | 26.31bn | 1.19bn | 43.73bn | 3.18k | 36.65 | 2.38 | 24.73 | 1.66 | 0.686 | 0.686 | 15.12 | 10.56 | 0.842 | 5.71 | 7.28 | 1,113,278.00 | 3.91 | -- | 4.73 | -- | 23.51 | -- | 4.65 | -- | 1.17 | 4.37 | 0.3537 | -- | 27.19 | -- | -4.52 | -- | -- | -- |
| Oci NV | 66.49bn | 10.25bn | 49.09bn | 3.72k | 4.80 | 2.36 | 2.09 | 0.7383 | 6.52 | 6.52 | 42.32 | 13.27 | 0.9829 | 12.58 | 11.24 | 2,406,394.00 | 27.71 | 1.83 | 44.90 | 2.58 | 38.25 | 20.65 | 28.19 | 4.15 | 1.32 | 16.17 | 0.388 | -- | 81.88 | 27.08 | 421.05 | 27.71 | -19.49 | -- |
| Arkema SA | 85.86bn | 7.81bn | 51.74bn | 20.20k | 6.76 | 0.8819 | 4.13 | 0.6027 | 13.71 | 13.71 | 151.44 | 105.12 | 0.8829 | 5.93 | 7.43 | 597,928.00 | 8.15 | 6.63 | 9.84 | 8.07 | 23.68 | 21.78 | 9.23 | 7.98 | 1.38 | 32.86 | 0.2902 | 27.67 | 20.74 | 4.79 | 325.33 | 24.81 | 9.62 | 7.91 |
| Imcd NV | 30.34bn | 2.07bn | 62.20bn | 4.01k | 29.96 | 5.20 | 22.39 | 2.05 | 4.90 | 4.90 | 71.63 | 28.24 | 1.21 | 6.00 | 5.54 | 1,090,717.00 | 8.30 | 5.64 | 11.71 | 7.82 | 21.78 | 20.28 | 6.84 | 4.65 | 1.04 | 19.70 | 0.4507 | 44.47 | 23.80 | 14.91 | 72.55 | 23.22 | 23.72 | 24.12 |
| Umicore SA | 187.55bn | 3.93bn | 63.72bn | 11.35k | 15.90 | 2.45 | 9.65 | 0.3398 | 2.19 | 2.19 | 104.41 | 14.20 | 2.57 | 7.63 | 11.34 | 1,848,767.00 | 5.42 | 4.89 | 9.72 | 8.12 | 5.85 | 6.51 | 2.11 | 1.84 | 0.8599 | 10.94 | 0.4127 | 35.61 | 16.15 | 18.16 | 374.19 | 27.87 | 7.67 | 3.83 |
| Chr Hansen Holding A/S | 9.36bn | 1.70bn | 65.53bn | 3.69k | 38.50 | 5.06 | 26.06 | 7.00 | 12.91 | 12.91 | 71.21 | 98.30 | 0.3936 | 3.24 | 7.75 | 2,535,703.00 | 7.14 | 8.94 | 8.05 | 11.09 | 55.28 | 57.57 | 18.14 | 21.00 | 0.9601 | 10.44 | 0.3769 | 62.46 | 13.05 | 2.77 | 13.29 | 0.098 | 5.96 | -10.07 |
| Akron PAO | 16.54bn | 5.63bn | 70.59bn | 11.21k | 11.52 | 7.51 | 10.29 | 4.27 | 1,562.54 | 1,562.54 | 4,595.30 | 2,395.29 | 0.7354 | 2.99 | 21.09 | -- | 25.34 | 8.40 | 35.98 | 12.17 | 59.90 | 47.34 | 34.46 | 15.83 | 1.10 | -- | 0.4489 | 81.99 | 4.38 | 5.43 | -86.33 | -26.95 | 3.50 | -19.73 |
| Evonik Industries AG | 135.65bn | 6.89bn | 70.71bn | 33.84k | 10.25 | 0.8116 | 4.71 | 0.5212 | 1.99 | 2.00 | 39.21 | 25.14 | 0.7936 | 4.77 | 8.68 | 552,599.70 | 4.10 | 3.35 | 5.08 | 4.01 | 24.20 | 28.76 | 5.17 | 5.13 | 0.9184 | -- | 0.3205 | 79.08 | 22.59 | 3.27 | 52.97 | 0.00 | -1.54 | 0.3454 |
| Novozymes A/S | 17.55bn | 3.68bn | 78.79bn | 6.44k | 26.29 | 6.93 | 15.24 | 4.49 | 13.19 | 13.19 | 62.96 | 50.03 | 0.6655 | 2.35 | 5.32 | 2,726,468.00 | 13.98 | 14.77 | 18.74 | 19.53 | 54.56 | 56.26 | 21.00 | 21.31 | 0.781 | 24.89 | 0.3249 | 47.21 | 17.40 | 3.85 | 16.85 | 3.34 | 11.30 | 5.92 |
| Yara International ASA | 161.14bn | 14.01bn | 79.36bn | 17.80k | 5.66 | 1.49 | 3.93 | 0.4925 | 79.51 | 79.51 | 914.29 | 301.64 | 1.39 | 4.40 | 10.36 | 13,083,640.00 | 11.72 | 2.81 | 16.60 | 3.57 | 26.46 | 26.57 | 8.45 | 3.50 | 0.7783 | 8.68 | 0.3418 | 150.29 | 43.36 | 7.93 | -35.02 | -9.93 | -12.00 | 30.70 |
| PhosAgro PAO | 56.83bn | 20.06bn | 80.43bn | 25.00k | 4.01 | 3.78 | 3.50 | 1.42 | 1,601.04 | 1,601.04 | 4,535.50 | 1,697.70 | 1.26 | 8.04 | 15.23 | -- | 44.58 | 16.47 | 62.88 | 21.01 | 52.98 | 43.38 | 35.30 | 18.21 | 1.02 | -- | 0.3904 | 91.15 | 65.63 | 17.50 | 665.99 | 16.71 | 3.57 | 31.48 |
| Brenntag SE | 139.36bn | 6.27bn | 80.44bn | 17.20k | 12.83 | 2.19 | 8.88 | 0.5772 | 5.45 | 5.45 | 121.23 | 31.99 | 1.70 | 8.42 | 7.18 | 1,087,056.00 | 7.79 | 5.51 | 11.48 | 7.66 | 22.43 | 22.24 | 4.59 | 3.52 | 1.19 | 13.35 | 0.4307 | 41.72 | 21.94 | 6.50 | -3.90 | 4.47 | 7.50 | 6.67 |
| Akzo Nobel NV | 79.16bn | 4.02bn | 88.07bn | 35.60k | 22.44 | 2.29 | 12.54 | 1.11 | 3.03 | 2.97 | 59.92 | 29.66 | 0.7342 | 3.73 | 4.05 | 324,481.70 | 3.94 | 4.02 | 6.15 | 5.65 | 36.65 | 42.73 | 5.37 | 6.61 | 0.7876 | 14.00 | 0.4986 | 76.42 | 12.39 | 0.3223 | 29.20 | 9.04 | -14.60 | 1.30 |
Data as of Jan 27 2023. Currency figures normalised to Novozymes A/S's reporting currency: Danish Krone DKK
19.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2021 | 8.06m | 3.55% |
| Baillie Gifford & Co.as of 19 Jan 2023 | 6.93m | 3.05% |
| MFS International (UK) Ltd.as of 30 Sep 2022 | 6.84m | 3.01% |
| The Vanguard Group, Inc.as of 05 Jan 2023 | 5.30m | 2.33% |
| BlackRock Fund Advisorsas of 05 Jan 2023 | 3.64m | 1.60% |
| Pictet Asset Management SAas of 31 Dec 2022 | 3.38m | 1.49% |
| Impax Asset Management Ltd.as of 30 Dec 2022 | 3.28m | 1.45% |
| Walter Scott & Partners Ltd.as of 19 Jan 2023 | 2.73m | 1.20% |
| Harding Loevner LPas of 31 Dec 2022 | 2.62m | 1.16% |
| Amundi Asset Management SA (Investment Management)as of 16 Jan 2023 | 2.58m | 1.13% |
More ▼
Data from 31 Dec 2021 - 16 Jan 2023Source: FactSet Research Systems Inc.
